These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27257808)

  • 61. [Treatment of severe hemophagocytic syndrome associated with visceral leishmaniasis].
    Bouguila J; Chabchoub I; Moncef Y; Mlika A; Saghrouni F; Boughamoura L; Essoussi AS
    Arch Pediatr; 2010 Nov; 17(11):1566-70. PubMed ID: 20880678
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effectiveness of Short-Course Meglumine Antimoniate (Glucantime®) for Treatment of Visceral Leishmaniasis: A 13-Year, Multistage, Non-Inferiority Study in Iran.
    Alborzi A; Pouladfar G; Attar A; Falahi F; Jafarpour Z; Karimi A; Kadivar MR
    Am J Trop Med Hyg; 2017 Jan; 96(1):182-189. PubMed ID: 27879460
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Treatment of Mediterranean visceral leishmaniasis.
    Gradoni L; Bryceson A; Desjeux P
    Bull World Health Organ; 1995; 73(2):191-7. PubMed ID: 7743590
    [TBL] [Abstract][Full Text] [Related]  

  • 64. First report of the use of meglumine antimoniate for treatment of canine leishmaniasis in a pregnant dog.
    Spada E; Proverbio D; Groppetti D; Perego R; Grieco V; Ferro E
    J Am Anim Hosp Assoc; 2011; 47(1):67-71. PubMed ID: 21164165
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Epidemiological situation of visceral leishmaniasis on the Island of São Luis, State of Maranhão].
    Silva AR; Tauil PL; Cavalcante MN; Medeiros MN; Pires BN; Gonçalves Eda G
    Rev Soc Bras Med Trop; 2008; 41(4):358-64. PubMed ID: 18853007
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Visceral leishmaniasis: a possible diagnosis in Belgium].
    Desmyttere S; Hachimi-Idrissi S; Otten J
    Tijdschr Kindergeneeskd; 1993 Oct; 61(5):182-5. PubMed ID: 8266313
    [TBL] [Abstract][Full Text] [Related]  

  • 67. How better drugs could change kala-azar control. Lessons from a cost-effectiveness analysis.
    Boelaert M; Le Ray D; Van Der Stuyft P
    Trop Med Int Health; 2002 Nov; 7(11):955-9. PubMed ID: 12390602
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Visceral leishmaniasis of favourable course in a patient with renal transplantation].
    Le Cacheux P; Hurault de Ligny B; Reman O; Ryckelynck JP
    Rev Med Interne; 1990; 11(3):250-1. PubMed ID: 2096427
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pharmacokinetic of meglumine antimoniate encapsulated in phosphatidylserine-liposomes in mice model: A candidate formulation for visceral leishmaniasis.
    Borborema SET; Osso Junior JA; Tempone AG; de Andrade Junior HF; do Nascimento N
    Biomed Pharmacother; 2018 Jul; 103():1609-1616. PubMed ID: 29864949
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Our experiences in visceral leishmaniasis therapy.
    Titone L; Scarlata F; Cascio A; Giordano S; Mancuso G
    J Chemother; 1989 Jul; 1(4 Suppl):960-1. PubMed ID: 16312722
    [No Abstract]   [Full Text] [Related]  

  • 71. Visceral leishmaniasis: bone marrow biopsy findings.
    Kumar PV; Vasei M; Sadeghipour A; Sadeghi E; Soleimanpour H; Mousavi A; Tabatabaei AH; Rizvi MM
    J Pediatr Hematol Oncol; 2007 Feb; 29(2):77-80. PubMed ID: 17279002
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Management of visceral leishmaniasis in rural primary health care services in Bihar, India.
    Hasker E; Singh SP; Malaviya P; Singh RP; Shankar R; Boelaert M; Sundar S
    Trop Med Int Health; 2010 Jul; 15 Suppl 2(Suppl 2):55-62. PubMed ID: 20591081
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Efficacy of cryotherapy versus intralesional meglumine antimoniate (glucantime) for treatment of cutaneous leishmaniasis in children.
    Layegh P; Pezeshkpoor F; Soruri AH; Naviafar P; Moghiman T
    Am J Trop Med Hyg; 2009 Feb; 80(2):172-5. PubMed ID: 19190206
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Visceral leishmaniasis in children. A study of hospitalized cases from 1974 to 1988 at the Children's Hospital in Tunis].
    Khaldi F; Achouri E; Gharbi A; Debbabi A; Ben Naceur B
    Med Trop (Mars); 1991; 51(2):143-8. PubMed ID: 1895911
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical and Parasitological Features of Patients with American Cutaneous Leishmaniasis that Did Not Respond to Treatment with Meglumine Antimoniate.
    Perez-Franco JE; Cruz-Barrera ML; Robayo ML; Lopez MC; Daza CD; Bedoya A; Mariño ML; Saavedra CH; Echeverry MC
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004739. PubMed ID: 27243811
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Preliminary study on tubuloglomerular dysfunction and evidence of renal inflammation in patients with visceral leishmaniasis.
    Oliveira MJ; Silva GB; Sampaio AM; Montenegro BL; Alves MP; Henn GA; Rocha HA; Meneses GC; Martins AM; Daher EF
    Am J Trop Med Hyg; 2014 Nov; 91(5):908-11. PubMed ID: 25114011
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The economic burden of visceral leishmaniasis for households in Nepal.
    Rijal S; Koirala S; Van der Stuyft P; Boelaert M
    Trans R Soc Trop Med Hyg; 2006 Sep; 100(9):838-41. PubMed ID: 16406035
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Meglumine Antimoniate (Glucantime) Causes Oxidative Stress-Derived DNA Damage in BALB/c Mice Infected by Leishmania (Leishmania) infantum.
    Moreira VR; de Jesus LCL; Soares RP; Silva LDM; Pinto BAS; Melo MN; Paes AMA; Pereira SRF
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320726
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comprehensive economic evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Colombia.
    Cardona-Arias JA; López-Carvajal L; Tamayo-Plata MP; Vélez ID
    BMC Public Health; 2018 Jan; 18(1):185. PubMed ID: 29378537
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Visceral Leishmaniasis Treatment Outcome and Associated Factors in Northern Ethiopia.
    Gidey K; Belay D; Hailu BY; Kassa TD; Niriayo YL
    Biomed Res Int; 2019; 2019():3513957. PubMed ID: 31531350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.